• Thurs news: Novo Nordisk’s port strike distribution plan. Arcus/AZ renal cancer trial. Lilly weight loss drugs no longer in shortage. Difficulties of a CVS breakup. Google and Biontech AI lab assistants. See more on our front page

Any news on the dry eye drug?


<







Seciera (OTX-1) NDA was accepted by the FDA in 2017. Not sure on the status as of late. Curious myself since this could be huge with Allergan's Restasis on the attack by patent expiration and multiple players fighting for a piece of the generic pie.